Patents matching “regimen”

US 11986449

Levodopa dosing regimen

AMNEAL PHARMACEUTICALS LLC · Granted May 21, 2024 · Expires May 16, 2044

US 11918627

Dosage regimen for inhaled vasoactive intestinal polypeptide

CENTURION ÌLAÇ SANAYI VE TICARET ANONIM SIRKETI · Granted Mar 5, 2024 · Expires Feb 29, 2044

US 11903994

Dosing regimens

Apellis Pharmaceuticals, Inc. · Granted Feb 20, 2024 · Expires Feb 15, 2044

US 11890272

Non-sedating dexmedetomidine treatment regimens

BioXcel Therapeutics, Inc. · Granted Feb 6, 2024 · Expires Feb 1, 2044

US 11844841

Dosing regimens and related compositions and methods

Apellis Pharmaceuticals, Inc. · Granted Dec 19, 2023 · Expires Dec 14, 2043

US 11839611

Buprenorphine dosing regimens

Indivior UK Limited · Granted Dec 12, 2023 · Expires Dec 7, 2043

US 11806334

Non-sedating dexmedetomidine treatment regimens

BioXcel Therapeutics, Inc. · Granted Nov 7, 2023 · Expires Nov 2, 2043

US 2023321198

Dosage Regimen for a Controlled-Release PTH Compound

ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Oct 12, 2023 · Expires Oct 7, 2043

US 11749394

Method and apparatus for providing a pharmacokinetic drug dosing regimen

Takeda Pharmaceutical Company Limited · Granted Sep 5, 2023 · Expires Aug 31, 2043

US 11744828

Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects

The Government of the United States, as represented by the Secretary of the Army · Granted Sep 5, 2023 · Expires Aug 31, 2043

US 11732037

Weight loss regimen

Boards of Regents, The University of Texas System · Granted Aug 22, 2023 · Expires Aug 17, 2043

US 11670409

Method and apparatus for providing a pharmacokinetic drug dosing regiment

Takeda Pharmaceutical Company Limited · Granted Jun 6, 2023 · Expires Jun 1, 2043

US 11590154

Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

RedHill Biopharma Ltd. · Granted Feb 28, 2023 · Expires Feb 23, 2043

US 11559567

Dosage regimen for pegylated interferon

PHARMAESSENTIA CORPORATION · Granted Jan 24, 2023 · Expires Jan 19, 2043

US 11419869

Dosage forms and regimens for amino acid compounds

Pliant Therapeutics, Inc. · Granted Aug 23, 2022 · Expires Aug 18, 2042

US 11129810

Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease

MEREO BIOPHARMA 1 LIMITED · Granted Sep 28, 2021 · Expires Sep 23, 2041

US 11040107

Dosing regimens and related compositions and methods

Apellis Pharmaceuticals, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

US 11000520

Buprenorphine dosing regimens

Indivior UK Limited · Granted May 11, 2021 · Expires May 6, 2041

US 2021128573

DOSING REGIMENS FOR USE IN TREATING MYELOFIBROSIS AND MPN-RELATED DISORDERS WITH NAVITOCLAX

ABBVIE INC [US] · Granted May 6, 2021 · Expires May 1, 2041

US 10888558

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

The Government of the United States, as represented by the Secretary of the Army · Granted Jan 12, 2021 · Expires Jan 7, 2041

US 10617674

Dosage regimen for the treatment of acute exacerbations of inflammatory conditions

MEREO BIOPHARMA 1 LIMITED · Granted Apr 14, 2020 · Expires Apr 9, 2040

US 10603306

Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease

MEREO BIOPHARMA 1 LIMITED · Granted Mar 31, 2020 · Expires Mar 26, 2040

US 10428157

Dosing regimens for use with PCSK9 inhibitors

REGENERON PHARMACEUTICALS, INC. · Granted Oct 1, 2019 · Expires Sep 26, 2039

US 10342791

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

The United States of America as represented by the Secretary of the Army · Granted Jul 9, 2019 · Expires Jul 4, 2039